Our preventive diagnostics division focuses on developing and deploying rapid diagnostic tests that enable early disease detection, empowering healthcare providers to make proactive interventions that improve patient outcomes.
We are revolutionizing the way infections are diagnosed by developing advanced diagnostic tools that bridge the gap between oral and systemic health. Our flagship product, the Multiplex Lateral Flow Assay (LFA) device, is at the forefront of infection diagnosis, offering a rapid and affordable way to detect periodontal pathogens that influence cardiovascular health.
With a clear focus on enhancing both oral and cardiovascular care, our diagnostic device provides healthcare professionals with an efficient, point-of-care solution. By enabling early detection of periodontal pathogens that contribute to systemic inflammation and cardiovascular complications, we aim to improve patient outcomes, support preventive care, and promote holistic health management.
Advanced diagnostic tests that identify diseases in their earliest stages for better treatment outcomes
Fast turnaround times enabling quick clinical decisions and immediate patient care
Precision testing with industry-leading sensitivity and specificity rates
Periodontal disease is no longer viewed as a localized oral condition, it’s increasingly recognized as a key contributor to systemic inflammation and chronic diseases such as cardiovascular disorders, diabetes, and adverse pregnancy outcomes. This article explores the complex pathogenesis linking oral pathogens to systemic health, emphasizing the role of inflammatory biomarkers such as CRP in early detection and risk assessment.
Through advances in Preventive Diagnostics, including rapid point-of-care tests and Multiplex Lateral Flow Assays (LFA), healthcare providers can now identify pathogenic and inflammatory signatures within minutes, enabling earlier intervention and better management of systemic risk factors.
Biomedisca’s diagnostic innovations aim to bridge the gap between dentistry and medicine, supporting a new paradigm of preventive, personalized, and data-driven healthcare, where early detection empowers proactive treatment and improved patient outcomes.
